Supplementary Tables from <i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas

Supplementary Table S1. Patient characteristics; Supplementary Table S2. Ki67 proliferation index; Supplementary Table S3. WES and WGS performance statistics; Supplementary Table S4. Amplicon sequencing primers; Supplementary Table S5. High confidence variants from exome and whole genome sequencing; Supplementary Table S6. Summary of SNVs and indels by sample; Supplementary Table S7. Significantly mutated genes (MuSiC output); Supplementary Table S8. Somatic variants in recurrently mutated genes; Supplementary Table S9. Validation cohort variants; Supplementary Table S10. TP53 variants in validation cohort; Supplementary Table S11. EIF1AX mutations reported in cancer